Evaluation of the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Postmenopausal Women
Evaluation of Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Autonomic and Psychophysical Parameters in Postmenopausal Women
1 other identifier
interventional
30
1 country
1
Brief Summary
Introduction: Menopause is the last menstrual period, it is a natural phenomenon to all women. Postmenopausal, some women may experience unpleasant symptoms such as hot flushes, urogenital pain, headache and pains in the musculoskeletal system. That happens due to the decreased ovarian hormone secretion and changes in the autonomic system. Pain is also caused by a complex autonomic activity. For pain management, a therapeutic electrical stimulation of the peripheral nervous system promotes modulation of nociceptive incentives and release of endogenous opioids. According to reviewed studies, the use of transcutaneous electrical nerve stimulation (TENS), by directly stimulating the central nervous system, has presented results of manipulation of the autonomic system, being observed change in heart rate and cognitive improvement in dementia. Given this possibility, the present study aims to investigate whether the use of Transcutaneous Electrical Nerve Stimulation in low frequency can generate autonomic and psychophysical changes in healthy postmenopausal women. Objective: To evaluate the effectiveness of Transcutaneous Electrical Nerve Stimulation on autonomic and psychophysical parameters in postmenopausal women. Methods: randomized, crossover, double-blind. A sample of thirty patients will be selected according to inclusion and exclusion criteria previously established. The autonomic and psychophysical functions will be evaluated by Quantitative Sensory Testing and Conditioned Pain Modulation (pain thresholds to heat and modulation of conditioned pain, respectively), as well as scales to evaluate catastrophism and sleep quality (by scale of Pittsburgh Sleep Quality Index). After application of the scales, the participants will be subject to active Ttranscutaneous Electrical Nerve Stimulation session or sham with a fortnight washout as randomization. All the research subjects will be invited to participate in the study and sign an Informed Consent and Informed (ICI). This study will be registered in the Clinical Trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jan 2017
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedFirst Posted
Study publicly available on registry
January 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedJanuary 26, 2017
January 1, 2017
6 months
January 22, 2016
January 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Autonomic changes in postmenopausal women's health
Heart rate's modification tested by R-R interval on electrocardiogram.
30 days
Psychophysical changes in postmenopausal women´s health
pain evaluated by Quality Sensitive Test
30 days
Secondary Outcomes (1)
Descendent Inibitory System Pain changes in postmenopausal women´s health
30 days
Study Arms (2)
Active TENS
ACTIVE COMPARATORActive TENS, 10 Hz/200 μs
Not Active TENS
SHAM COMPARATORSham TENS
Interventions
Eligibility Criteria
You may qualify if:
- To be in the period of post-menopause;
- Do not have chronic diseases or comorbidities in drug treatment;
- Accept to participate in the study and sign the free and informed consent form.
You may not qualify if:
- Start continuous medication during the study period;
- Display cognitive problems that make it difficult to understand the questionnaires and proposals;
- History of alcohol or drug abuse in the last 6 months;
- History of neurological disorders;
- History of cardiac arrhythmias;
- History of moderate or severe head injury;
- History of neurosurgery;
- Uncompensated systemic diseases, and chronic inflammatory diseases (diabetes, lupus, rheumatoid arthritis, Sjogren's syndrome, Reiter's syndrome);
- History of uncompensated hypothyroidism;
- History of personal cancer, past or treatment.
- Wish referred to leave the study at any time.
- No attendance to the stages that make up the research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Andressa de Souza
Canoas, Rio Grande do Sul, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master of Science
Study Record Dates
First Submitted
January 22, 2016
First Posted
January 26, 2017
Study Start
January 1, 2017
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
January 26, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will share